Imipenem Cannot Be Administered Orally
Imipenem is only available as an intravenous formulation and cannot be given by mouth. The FDA-approved drug label explicitly states that imipenem-cilastatin is "for intravenous use" only 1. All clinical guidelines and research consistently describe imipenem as an intravenous antibiotic without any oral formulation 2, 3, 2, 4.
Why Imipenem Must Be Given Intravenously
- No oral formulation exists: The drug is manufactured only as a sterile powder for reconstitution and intravenous infusion 1
- Pharmacokinetic requirements: Imipenem requires intravenous administration to achieve therapeutic serum levels, with mean peak concentrations of 18.4 mcg/mL achieved 30 minutes after a 500 mg IV infusion 5
- Renal metabolism protection: Imipenem must be co-administered with cilastatin intravenously to prevent its rapid degradation by renal dehydropeptidase enzymes 1, 6
Clinical Context in Guidelines
When guidelines discuss transitioning from intravenous to oral therapy for various infections, imipenem is never mentioned as an oral option 2. For example:
- Mycobacterial infections: Guidelines describe an "intensive phase" using intravenous imipenem, followed by a "continuation phase" with oral antibiotics (macrolides, linezolid, clofazimine, moxifloxacin)—but imipenem itself is discontinued, not converted to oral form 2
- Intra-abdominal infections: When oral step-down therapy is appropriate, imipenem is replaced with entirely different oral agents 3
Common Clinical Pitfall
Do not confuse imipenem with ertapenem, another carbapenem that also requires intravenous administration. Neither has an oral formulation, despite both being beta-lactam antibiotics 3, 4. If oral therapy is needed, alternative antibiotic classes must be selected based on the specific pathogen and susceptibility patterns 2, 3.